# EDGAR Filing Document

**Accession Number:** 0001744967
**File Stem:** 0001104659-25-086390
**Filing Date:** 2025-9
**Character Count:** 9396
**Document Hash:** 1721f154ec0f949015ce987f3d0947aa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-086390.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001104659-25-086390

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Samsara BioCapital, LLC
- **CENTRAL INDEX KEY:** 0001744967

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-19375
- **FILM NUMBER:** 251285776

**BUSINESS ADDRESS:**
- **STREET 1:** 628 MIDDLEFIELD ROAD
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94301
- **BUSINESS PHONE:** (650) 285-4270

**MAIL ADDRESS:**
- **STREET 1:** 628 MIDDLEFIELD ROAD
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94301

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001744967

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Samsara BioCapital, LLC

**Address:** 628 Middlefield Road, Palo Alto, CA 94301

**Telephone number:** 650-285-4270

**Name of agent for service:** Miran Ahmad

**Agent Address:** c/o Samsara BioCapital, LLC, Palo Alto, CA 94301

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-19375

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER             | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Arcellx Inc                | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. | SECTION 14A SAY-ON-PAY VOTES |         135276 |                0 | FOR         |                                   135276 | FOR                         |  |
| Avadel Pharmaceuticals plc | G29687103 | 07/30/2024     | To approve, on a non-binding advisory basis, the the compensation of the named executive officers of the Company                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         384784 |                0 | FOR         |                                   384784 | FOR                         |  |
| Curis Inc                  | 231269309 | 05/20/2025     | To approve on an advisory vote on executive compensation.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         185943 |                0 | FOR         |                                   185943 | FOR                         |  |
| Gossamer Bio Inc           | 38341P102 | 06/25/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.                                                                   | SECTION 14A SAY-ON-PAY VOTES |        3119396 |          3010872 | FOR         |                                  3119396 | FOR                         |  |
| Leap Therapeutics Inc      | 52187K200 | 07/02/2024     | Advisory vote on executive compensation paid to the named executive officers ("Say-on-Pay Proposal").                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         602203 |                0 | FOR         |                                   602203 | FOR                         |  |
| Leap Therapeutics Inc      | 52187K200 | 06/18/2025     | Advisory vote on executive compensation paid to the named executive officers ("Say-on-Pay Proposal").                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        2413076 |            29276 | FOR         |                                  2413076 | FOR                         |  |
| Neurogene Inc              | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        1717127 |                0 | FOR         |                                  1717127 | FOR                         |  |
| Palvella Therapeutics Inc  | 697947109 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |                                        0 | NONE                        |  |
| Rhythm Pharmaceuticals Inc | 76243J105 | 09/18/2024     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |                                        0 | NONE                        |  |
| Rhythm Pharmaceuticals Inc | 76243J105 | 06/24/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         110495 |                0 | FOR         |                                   110495 | FOR                         |  |
| Scholar Rock Holding Corp  | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        5612896 |                0 | FOR         |                                  5612896 | FOR                         |  |
| Sutro Biopharma Inc        | 869367102 | 06/06/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2196814 |                0 | FOR         |                                  2196814 | FOR                         |  |
| Tango Therapeutics, Inc.   | 87583X109 | 06/05/2025     | Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.                                                               | SECTION 14A SAY-ON-PAY VOTES |         630000 |                0 | 1 YEAR      |                                   630000 | FOR                         |  |
| Tango Therapeutics, Inc.   | 87583X109 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         630000 |                0 | FOR         |                                   630000 | FOR                         |  |
| Zymeworks Inc              | 98985Y108 | 12/10/2024     | Advisory Vote on the compensation of named executive officers                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1000000 |                0 | FOR         |                                  1000000 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Samsara BioCapital, LLC

**By (Signature):** Miran Ahmad

**By (Printed Signature):** Miran Ahmad

**By (Title):** Chief Financial Officer

**Date:** 09/02/2025